New dosing model helps severely ill children hit drug targets faster

Critically ill children often struggle to get the right amount of medicine in their blood. This trial tested a new way to calculate vancomycin doses using early blood samples and special software. The goal was to hit a specific target quickly without causing harm. The study involved 332 patients across hospitals in Belgium. Half received standard care while the other half used the new model-informed precision dosing approach. The results showed clear benefits for the group using the new method. More patients in this group reached the target drug level within 24 to 48 hours compared to the standard group. This means the medicine worked as intended for a larger number of kids faster. Safety was also a major focus for the researchers. They looked closely for signs of kidney injury or death. The numbers showed a lower rate of these bad outcomes in the new method group. However, the difference was not statistically significant. This means the result could have happened by chance. One patient in the new group died, but the cause was not clearly linked to the dosing method. The study team noted that doctors and pharmacists knew which group each patient was in. This lack of blinding might have influenced the results slightly. Despite this, the findings suggest the new method is safe and effective for severely ill children.